Brief: CEO Ulf Jungnelius To Leave Isofol Medical On June 1, 2023
Nov 28 (Reuters) - Isofol Medical AB (publ) ISOFOL.ST :
* CEO ULF JUNGNELIUS TO LEAVE ISOFOL MEDICAL ON JUNE 1, 2023
* BOARD OF DIRECTORS WILL TAKE A DECISION REGARDING A NEW
CEO ONCE
COMPANY'S FUTURE HAS BEEN DETERMINED
Source text for Eikon: ID:nWkr3bfwSj
Further company coverage: ISOFOL.ST
((Reuters.briefs@thomsonreuters.com;))
Recent news on Isofol Medical AB (publ)
See all newsSweden's Isofol Medical Q1 net loss widens, raises funds
Brief: Isofol Medical Q1 Net Income SEK -15.062 Million
Brief: Isofol Medical Announces Bfarm Approval Of Optimized Phase Ib/Ii Study Design
Brief: Isofol Gets Gross Proceeds Of SEK 18.9 Mln In Connection With Exercise Of Warrants And Guarantee Commitments
Brief: Isofol Secures License Rights For Arfolitixorin In Autism